(Q39832852)

15 September 2017

title

Evaluation of the radiocobalt-labeled [MMA-DOTA-Cys61]-Z HER2:2395(-Cys) affibody molecule for targeting of HER2-expressing tumors (English)

1 reference

15 September 2017

Helena Wållberg

1

1 reference

15 September 2017

Sara Ahlgren

series ordinal

2

1 reference

15 September 2017

Charles Widström

series ordinal

3

1 reference

15 September 2017

Anna Orlova

series ordinal

4

1 reference

15 September 2017

publication date

26 June 2009

1 reference

Molecular Imaging and Biology

15 September 2017

published in

1 reference

15 September 2017

volume

12

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

54-62

1 reference

In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems

15 September 2017

cites work

1 reference

12 December 2020

Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.

1 reference

12 December 2020

55Co-EDTA for renal imaging using positron emission tomography (PET): a feasibility study.

1 reference

12 December 2020

[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography

1 reference

12 December 2020

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

1 reference

12 December 2020

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

12 December 2020

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

1 reference

12 December 2020

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

1 reference

12 December 2020

Site-specifically conjugated anti-HER2 Affibody molecules as one-step reagents for target expression analyses on cells and xenograft samples

1 reference

12 December 2020

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

12 December 2020

Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules

1 reference

12 December 2020

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

12 December 2020

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

1 reference

12 December 2020

Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors

1 reference

12 December 2020

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues

1 reference

12 December 2020

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules

1 reference

12 December 2020

Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis

1 reference

12 December 2020

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.

1 reference

12 December 2020

Targeting peptides and positron emission tomography

1 reference

12 December 2020

Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules

1 reference

12 December 2020

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy

1 reference

12 December 2020

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.

1 reference

12 December 2020

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

1 reference

12 December 2020

Visualization of damaged brain tissue after ischemic stroke with cobalt-55 positron emission tomography

1 reference

12 December 2020

Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting

1 reference

12 December 2020

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake.

1 reference

12 December 2020

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

1 reference

12 December 2020

Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.

1 reference

12 December 2020

Update: affibody molecules for molecular imaging and therapy for cancer.

1 reference

12 December 2020

10.1007/S11307-009-0238-8

Identifiers

DOI

1 reference

15 September 2017

1 reference